home / stock / mdma:cc / mdma:cc news

MDMA:CC News and Press, Pharmala Biotech Holdings Inc. From 10/16/25

Stock Information
Company Name: Pharmala Biotech Holdings Inc.
Stock Symbol: MDMA:CC
Market: CNQC
Website: pharmala.ca
Menu
MDMA:CC MDMA:CC Quote MDMA:CC Short MDMA:CC News MDMA:CC Articles MDMA:CC Message Board
Get MDMA:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
MDMA:CC - CSE Bulletin: MOC Eligibility Update

Toronto, Ontario--(Newsfile Corp. - October 16, 2025) - The following CSE-Listed symbol will become MOC Eligible as detailed below.   The full list of MOC-Eligible symbols is available at https://thecse.com/trading/trading-resources/#market-on-close . For further information, pl...
MDMA:CC - Small Cap Growth Virtual Investor Conference Agenda Announced for October 16th

NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Small Cap Growth Virtual Investor Conference to be held October 16 th . Individual investors, institutional investors, advisors, and an...

MDMA:CC - PharmAla Launches Nexus Portal for MDMA Prescribers and Therapists

TORONTO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of...

MDMA:CC - PharmAla Completes Shipment of LaNeo(TM) MDMA to Johns Hopkins

TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its L...
MDMA:CC - PharmAla Partners with Veridion Group as Exclusive Distributor in New Zealand

TORONTO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its ...

MDMA:CC - PharmAla Files Amended and Restated Preliminary Base Shelf Prospectus

TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its La...

MDMA:CC - PharmAla Completes Import of LaNeo MDMA for US Distribution

TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its La...
MDMA:CC - PharmAla Incorporates Australian Entity for Clinical Research

TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its La...

MDMA:CC - PharmAla Delivers MDMA to Merhavim Mental Health Centre Clinical Trial in Exchange for Full Data License

TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of M...

MDMA:CC - PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of ...
Previous 10 Next 10